# Ultra-low Dose Contrast for Endovascular Procedures

> **NCT06835127** · — · COMPLETED · sponsor: **Attikon Hospital** · enrollment: 18 (actual)

## Conditions studied

- Renal Impairment
- Limb Ischemia, Critical

## Interventions

- **PROCEDURE:** Infrainguinal peripheral endovascular revascularization

## Key facts

- **NCT ID:** NCT06835127
- **Lead sponsor:** Attikon Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-01
- **Primary completion:** 2026-01-23
- **Final completion:** 2026-01-23
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06835127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06835127, "Ultra-low Dose Contrast for Endovascular Procedures". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06835127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*